Dr. Rudy Dekeyzer

Dr. Rudy Dekeyser is Partner at LSP, a leading European venture capital firm with 2 billion Euro under management and investing in healthcare companies from seed to late stage in the fields of drug discovery, drug development, medical devices, diagnostics and digital health. Prior to joining LSP in 2012, Rudy has been managing director of VIB, an entrepreneurial life sciences research institute which he co-founded with Jo Bury in 1995. Rudy has also been intimately involved in the foundation of several bio-incubators, bio-accelerators, the European Association of Science and Technology Managers and Oncode, a Dutch research institute in the field of cancer. Rudy has been/is chairman/non-executive director at Ablynx (acquired by Sanofi), Actogenix (acquired by Intrexon), Multiplicom (acquired by Agilent), CropDesign (acquired by BASF), Devgen (acquired by Syngenta), QBiologicals (acquired by Amatsi), Curetis (listed), Sequana Medical (listed), Celyad (listed) and Lumeon and is also chairman/board member of several non-profit life sciences initiatives such as EMBLEM, De Weijerhorst Stichting, Fonds Généret and the Fonds Fournier-Majoie.

October 21, 2020 Webinar: Drug Discovery Powered by HUB Organo... Drug Discovery Powered by HUB Organoids and OcellO 3D Image Analysis Summary: More clinically relevant models are urgent... read more
September 04, 2020 HUB and BGI-Qingdao sign a Memorandum of Unde... Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ... read more
May 27, 2020 Studying the development of ovarian cancer wi... read more